Do Self-Rated Performance Status Scores Correlate With Health-Care-Provider-Scores?

Cancer Clinical Trial

Official title:

Do Self-Rated Karnofsky Performance Status (KPS) Scores Correlate With Health-Care-Provider-Rated Scores?

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00735111
• Other study ID #: QOL-001
• Status: Completed
• Phase: N/A
• First received: August 13, 2008
• Last updated: January 15, 2013
• Start date: February 2008
• Est. completion date: November 2011

Study information

• Verified date: January 2013
• Source: University of Florida
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine if patients are able to self-rate their physical abilities and how these ratings compare to the ratings of their health-care provider.

Description:

The Karnofsky Performance Scale (KPS) is a highly validated and essential measuring tool across the cancer population. The scale relates to purely physical ability and covers 11 stages, ranging from normal health to death, with each stage scored as a percentage. The score is determined by the health-care provider and is based on observation and narrative patient descriptions. The purpose of this study is to compare the scores rated by the health-care provider to the scores that patients assign to themselves.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 200
• Est. completion date: November 2011
• Est. primary completion date: November 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 90 Years

Eligibility

Inclusion Criteria:

• Patients with a diagnosis of brain or spinal tumor.

• Receiving medical care under the supervision of the Principal Investigator.

• Written informed consent.

Exclusion Criteria:

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label

Related Conditions & MeSH terms

• Cancer

Intervention

Other:
• Karnofsky Performance Status Score
Karnofsky Performance Status scores will be independently completed by both the patient and their health-care provider at each routine clinic visit.

Locations

Country	Name	City	State
United States	University of Florida	Gainesville	Florida

Sponsors (1)

Lead Sponsor	Collaborator
University of Florida

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	To determine the correlation between self-rated and health-care-provider-rated Karnofsky Performance Status scores.		2 Years	No